Insulin as a physiological modulator of glucagon secretion.
about
DAX-1 acts as a novel corepressor of orphan nuclear receptor HNF4alpha and negatively regulates gluconeogenic enzyme gene expressionPancreatic α-Cell Dysfunction in Type 2 Diabetes: Old Kids on the BlockIsosteviol has beneficial effects on palmitate-induced α-cell dysfunction and gene expressionOral treatment with γ-aminobutyric acid improves glucose tolerance and insulin sensitivity by inhibiting inflammation in high fat diet-fed miceChemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapiesGABA coordinates with insulin in regulating secretory function in pancreatic INS-1 β-cells.Insulin reciprocally regulates glucagon secretion in humansAMPK-dependent repression of hepatic gluconeogenesis via disruption of CREB.CRTC2 complex by orphan nuclear receptor small heterodimer partner.Model for glucagon secretion by pancreatic α-cells.Partial inhibition of insulin secretion results in glucose intolerance but not hyperglucagonemia.Comparison of the physiological relevance of systemic vs. portal insulin delivery to evaluate whole body glucose flux during an insulin clampGABAergic system in the endocrine pancreas: a new target for diabetes treatment.CrbpI modulates glucose homeostasis and pancreas 9-cis-retinoic acid concentrations.Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes.Metformin, but not glimepiride, improves carotid artery diameter and blood flow in patients with type 2 diabetes mellitus.Nodal induces apoptosis through activation of the ALK7 signaling pathway in pancreatic INS-1 β-cells.Study of GABA in Healthy Volunteers: Pharmacokinetics and Pharmacodynamics.A computational systems analysis of factors regulating α cell glucagon secretion.Intra-islet glucagon secretion and action in the regulation of glucose homeostasis.A mixed mirror-image DNA/RNA aptamer inhibits glucagon and acutely improves glucose tolerance in models of type 1 and type 2 diabetes.Current insights and new perspectives on the roles of hyperglucagonemia in non-insulin-dependent type 2 diabetes.Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetes.Adenosine, adenosine receptors and their role in glucose homeostasis and lipid metabolism.Disease signatures are robust across tissues and experiments.Evolution of glucose utilization: glucokinase and glucokinase regulator protein.Endospanin1 affects oppositely body weight regulation and glucose homeostasis by differentially regulating central leptin signaling.Basal insulin: physiology, pharmacology, and clinical implications.Functional implications of long non-coding RNAs in the pancreatic islets of Langerhans.The role of glucagon on type 2 diabetes at a glance.Dual-hormone treatment with insulin and glucagon in patients with type 1 diabetes.Late sodium current (INaL) in pancreatic β-cells.Aptamers: novel diagnostic and therapeutic tools for diabetes mellitus and metabolic diseases.Secondary consequences of beta cell inexcitability: identification and prevention in a murine model of K(ATP)-induced neonatal diabetes mellitus.Cortisone induces insulin resistance in C2C12 myotubes through activation of 11beta-hydroxysteroid dehydrogenase 1 and autocrinal regulation.A possible primary cause of cancer: deficient cellular interactions in endocrine pancreas.Increasing glucagon secretion could antagonize the action of exogenous insulin for glycemic control in streptozocin-induced diabetic rhesus monkeys.Ectopic expression of glucagon receptor in skeletal muscles improves glucose homeostasis in a mouse model of diabetes.The role of glucagon in weight loss-mediated metabolic improvement: a systematic review and meta-analysis.Enteroinsular hormones in two siblings with Donohue syndrome and complete leptin deficiency.Ablation of somatostatin cells leads to impaired pancreatic islet function and neonatal death in rodents.
P2860
Q24320012-62087AA9-C895-48B4-983B-251FEBA0ACA1Q26825393-ACD4DF76-6227-4C3D-BE98-42A300D034FCQ28481674-9BB6A45E-9880-447B-9F49-8CEA2AC7FF60Q28744643-DDF6B2C6-B35C-4E40-96A9-C97FC5337DD5Q33624771-C9689231-4A2C-453F-952B-09A1FD6616F2Q34059609-B06146DE-AA73-4712-B843-C9E04E2B552CQ34135501-4CCD3A5A-EDF6-41BE-A0FD-CCA56828E6F8Q34186447-0A6EB25F-2F8A-4929-B9F7-B5F11325AF34Q34193086-15AF02C3-9DA1-4453-BE53-49D59F716B62Q34718921-3F8E6A57-CF56-49E6-AE2A-D1C9B864377EQ35034818-7B1E989A-34AC-4C6C-9BBA-642D1FD2B7B4Q35067598-03DDB5B2-ECB8-46D6-8BBF-1E8185033749Q35139983-F87D70FF-5A03-49B8-A62D-92F71C54736DQ35762651-38056D09-8DD2-40AF-AC84-54A8CE036F89Q36104044-E25C0EF2-05AC-483B-B250-A7EEA92B1B58Q36114856-94D1E668-F05C-44B8-BCFF-E96B99F06D85Q36265459-C6BDB275-E3B3-45AC-8334-7E7367B1786FQ36394674-EF5D8032-C401-4407-9A99-818E05F6DF8CQ36516806-6E8EB10C-076C-4B61-B9A5-03C8F8CC84C7Q37175145-52CA3065-4FF8-4F4B-947F-50060BCACF3EQ37260041-72383A3B-7FDA-4A0D-A528-A3A9CFC4BE07Q37360316-A0D69B94-2B16-485E-9ADE-F2A6EBD4144AQ37360635-EDB814F7-CF2D-4F5B-9C98-5BB3C24DA8C0Q37379502-B282F5EC-8055-4AA0-92E5-84734DD4F28EQ37499429-5A363504-45F5-4BBC-ABC4-F1CFFBDA2FA3Q37571001-E4584972-B616-4B96-977A-652AF22093BEQ37890774-D6F32EEE-EC2F-4EE3-8EFC-9B16B8A673AEQ38234967-C45BB26E-55BB-4B3C-BCE7-0143BF2D571EQ38245233-7C7A7EDD-45FF-4A7D-ABC8-2A8C8462D160Q38297682-FFFADD1F-7629-4C41-B79C-F1299346ADC4Q38955138-F11637F6-1CD7-4A60-90F9-4B6A1089FB6DQ39009713-1C01891C-8A9B-41E5-8500-A52DE28ED31BQ39035715-E25ED23A-89CB-4E3E-AE7F-83CFA7A51804Q39079582-8BE98489-763B-4BD1-843F-E243CA1C1972Q42324345-E6E4B9E8-4E05-42FD-8B14-418F2ED7A357Q42439814-223037FC-E45F-4D11-8ED1-DB4FBF384248Q42501816-AE4E0F7D-439E-4821-8021-F25C772BF229Q47176353-E61AEE5A-BBC1-4F1A-AFCC-37E3809EF9F5Q48046764-344FE5A4-0E78-4DA1-84C1-FCE4C1B424D9Q55104419-BF4B533F-12B0-4BD1-9F5D-4BA59EB31A8E
P2860
Insulin as a physiological modulator of glucagon secretion.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Insulin as a physiological modulator of glucagon secretion.
@en
Insulin as a physiological modulator of glucagon secretion.
@nl
type
label
Insulin as a physiological modulator of glucagon secretion.
@en
Insulin as a physiological modulator of glucagon secretion.
@nl
prefLabel
Insulin as a physiological modulator of glucagon secretion.
@en
Insulin as a physiological modulator of glucagon secretion.
@nl
P2860
P1476
Insulin as a physiological modulator of glucagon secretion.
@en
P2093
Pritpal Bansal
Qinghua Wang
P2860
P304
P356
10.1152/AJPENDO.90295.2008
P577
2008-07-22T00:00:00Z